Pricing Log in Create free account

Sionna Therapeutics, Inc. (SION) vs Sutro Biopharma, Inc. (STRO)

Sionna Therapeutics, Inc. and Sutro Biopharma, Inc. are both Biotechnology companies. Sionna Therapeutics, Inc. and Sutro Biopharma, Inc. are of similar size ($190.0M and $184.5M). Sionna Therapeutics, Inc. has the higher net margin (0.00% vs −395.3%) and the lower return on invested capital (−125.0% vs 0.00%). Across the 11 metrics below, Sionna Therapeutics, Inc. leads on 8 and Sutro Biopharma, Inc. on 3.

Valuation

Metric SION STRO Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.94 9.71
P/B 0.66 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.32 n/m 0.64
EV/Sales n/m 0.52 9.21
Earnings yield (56.04%) (159.37%) (33.15%)
Free cash flow yield (43.44%) (80.84%) (25.50%)

Profitability

Metric SION STRO Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (319.57%) 0.00%
Net margin 0.00% (395.25%) 0.00%
Free cash flow margin 0.00% (318.63%) 0.00%
Return on equity (32.34%) 266.76% (56.36%)
Return on assets (30.66%) (79.08%) (48.04%)
Return on invested capital (125.00%) 0.00% 0.00%

Growth

Metric SION STRO Biotechnology median
Revenue growth (TTM) — (56.25%) 6.02%
EPS growth (last fiscal year) 88.24% 24.02% 30.26%
Revenue growth, 5-year CAGR — 19.12% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric SION STRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 20.05 3.32 4.72
Net debt to EBITDA 2.58 0.92 0.96

Dividend

Metric SION STRO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SION STRO Biotechnology median
Market cap 184.47m 190.02m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack